Non Prescription Weight Loss Pill Gets European Go Ahead

Drug company GlaxoSmithKline (GSK) has received the go ahead to market its non-prescription weight loss pill alli (orlistat) in Europe; the drug has already been on sale over the counter in the US for over year. News came in yesterday, Wednesday 21 January, that the European Medicines Agency (EMEA) has granted license to GSK to market its non-prescription weight loss pill alli (orlistat 60mg) in all 27 member countries of the European Union, plus Norway.

More: continued here

Filed under: Obesity / Weight Loss / Fitness on January 25th, 2009